Heart failure & cardiomyopathies

Incidence and risk factors for malignancy after heart transplantation- Analysis of the UNOS Registry

Am Heart JPublished Retrospective cohort study

Authors' conclusion

De novo malignancy is common, occurring in one-fifth of recipients after heart transplant. Risk factors for de novo malignancy included older age, male gender, induction immunosuppression, and history of cigarette use. Hospitalization for infection is a risk factor that has not been previously described.

Study context

Population
Heart transplant recipients, United Network for Organ Sharing registry
Participants
50,370 recipients
Outcome
Incidence of de novo post-transplant malignancy
Follow-up
10 years
Methodological detailsregistry analysis (UNOS)
  • Registry analysis (UNOS)

Main finding

As reported in the abstract

De novo post-transplant malignancy

Incidence of de novo post-transplant malignancy

20.6%

Observational data: associations, not effects.

Further findings

Risk factors for de novo malignancy

OR (95% CI)
Older age1.05 (1.049–1.060)
Induction with OKT31.47 (1.23–1.76)
>1 induction agent1.44 (1.14–1.82)
History of cigarette use1.19 (1.11–1.28)
Hospitalization for infection1.26 (1.18–1.34)
OutcomeOR (95% CI)
Risk factors for de novo malignancyFemalevs Male0.63 (0.58–0.68)

Incidence by malignancy type · 10 years

Nonmelanoma skin cancer
9.0%
Solid-organ cancer
6.2%
Lymphoproliferative disorder
1.2%

Original publication

Incidence and risk factors for malignancy after heart transplantation- Analysis of the UNOS Registry. Am Heart J. Published 21 November 2025. doi:10.1016/j.ahj.2025.107308

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.